Stock Based Compensation (Tables)
|
9 Months Ended |
Sep. 30, 2020 |
Share-based Payment Arrangement, Noncash Expense [Abstract] |
|
Schedule of stock-based compensation expense |
The amount of stock-based compensation expense recognized for the three and nine months ended September 30, 2020 and 2019 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
Research and development |
|
$ |
384,041 |
|
|
$ |
176,261 |
|
|
$ |
1,156,317 |
|
|
$ |
354,347 |
|
General and administrative |
|
971,558 |
|
|
473,905 |
|
|
3,959,156 |
|
|
1,139,241 |
|
Sales and marketing |
|
91,932 |
|
|
57,168 |
|
|
233,955 |
|
|
134,819 |
|
Total stock-based compensation, continuing operations |
|
1,447,531 |
|
|
707,334 |
|
|
5,349,428 |
|
|
1,628,407 |
|
Total stock-based compensation, discontinued operations |
|
— |
|
|
111,459 |
|
|
— |
|
|
313,789 |
|
Total stock-based compensation |
|
$ |
1,447,531 |
|
|
$ |
818,793 |
|
|
$ |
5,349,428 |
|
|
$ |
1,942,196 |
|
|
Summary of option activity |
A summary of option activity for the nine months ended September 30, 2020 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
|
Number of shares |
|
Weighted average exercise price per share |
|
Weighted average grant date fair value per share |
|
Weighted average remaining contractual term (in years) |
Balance at December 31, 2019 |
|
4,180,606 |
|
|
$ |
4.80 |
|
|
$ |
2.67 |
|
|
7.9 |
Granted |
|
5,630,953 |
|
|
$ |
3.44 |
|
|
$ |
2.19 |
|
|
|
Exercised |
|
(50,239) |
|
|
$ |
1.84 |
|
|
$ |
1.22 |
|
|
|
Forfeited |
|
(629,300) |
|
|
$ |
3.26 |
|
|
$ |
1.95 |
|
|
|
Expired |
|
(583,758) |
|
|
$ |
5.42 |
|
|
$ |
3.02 |
|
|
|
Balance at September 30, 2020 |
|
8,548,262 |
|
|
$ |
3.99 |
|
|
$ |
2.39 |
|
|
7.9 |
|
|
|
|
|
|
|
|
|
Exercisable at September 30, 2020 |
|
2,729,880 |
|
|
$ |
4.45 |
|
|
$ |
2.49 |
|
|
4.9 |
The Company has granted options that contain market-based vesting conditions. The following table summarizes the Company's market-based option activity for the nine months ended September 30, 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
|
Number of shares |
|
Weighted average exercise price per share |
|
Weighted average remaining contractual term (in years) |
|
Aggregate intrinsic value (1) |
Balance at December 31, 2019 |
|
300,000 |
|
|
$ |
4.98 |
|
|
9.4 |
|
|
Granted |
|
1,000,000 |
|
|
$ |
3.29 |
|
|
9.7 |
|
|
Forfeited |
|
(300,000) |
|
|
|
|
|
|
|
Balance at September 30, 2020 |
|
1,000,000 |
|
|
$ |
3.29 |
|
|
9.7 |
|
|
|
|
|
|
|
|
|
|
|
Exercisable at September 30, 2020 |
|
500,000 |
|
|
|
|
|
|
$ |
— |
|
(1) The aggregate intrinsic value in the above table represents the total pre-tax amount that a participant would receive if the option had been exercised on the last day of the respective fiscal period. Options with a market value less than its exercise value are not included in the intrinsic value amount.
|
Schedule of fair value assumptions for options |
The following table shows the assumptions used to compute stock-based compensation expense for stock options with service-based vesting conditions granted to employees and members of the board of directors under the Black-Scholes valuation model for the nine months ended September 30, 2020:
|
|
|
|
|
|
|
|
|
Service-based options |
|
|
Expected dividend yield |
|
—% |
Expected volatility |
|
69.9% - 79.0% |
Expected life (in years) |
|
1.75 - 6.25 |
Risk-free interest rate |
|
0.19% - 1.48% |
|
|
|
Nonvested Restricted Stock Shares Activity |
The following table summarizes the Company's RSU activity for the nine months ended September 30, 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RSUs Outstanding |
|
|
Number of shares |
|
Weighted average grant date fair value |
Unvested RSUs at December 31, 2019 |
|
267,500 |
|
|
$ |
4.92 |
|
Vested |
|
(111,667) |
|
|
$ |
4.93 |
|
Unvested RSUs at September 30, 2020 |
|
155,833 |
|
|
$ |
4.91 |
|
|